TMC-649128 Uses, Dosage, Side Effects and more
TMC-649128 is under investigation in clinical trial NCT01391117 (TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of TMC649128, Alone and Combined With Pegylated Interferon + Ribavirin).
| Trade Name | TMC-649128 |
| Generic | TMC-649128 |
| Type | |
| Formula | C18H26N6O6 |
| Weight | Average: 422.442 Monoisotopic: 422.191382581 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
